- call +1-201-465-4211
- email sales@mrinsights.biz
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Scope of the Report:
In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.
The worldwide market for Radiopharmaceuticals is expected to grow at a CAGR of roughly 7.8% over the next five years, will reach 7130 million US$ in 2024, from 4900 million US$ in 2019, according to a new study.
This report focuses on the Radiopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Market Segment by Applications, can be divided into
Oncology
Cardiology
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals, with price, sales, revenue and global market share of Radiopharmaceuticals in 2017 and 2018.
Chapter 3, the Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Diagnostic Radioisotopes
1.2.2 Therapeutic Radioisotopes
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Business Overview
2.1.2 Radiopharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Radiopharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mallinckrodt
2.3.1 Business Overview
2.3.2 Radiopharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Nordion
2.4.1 Business Overview
2.4.2 Radiopharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Nordion Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Triad Isotopes
2.5.1 Business Overview
2.5.2 Radiopharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Lantheus
2.6.1 Business Overview
2.6.2 Radiopharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lantheus Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 IBA Group
2.7.1 Business Overview
2.7.2 Radiopharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 IBA Group Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 GE Healthcare
2.8.1 Business Overview
2.8.2 Radiopharmaceuticals Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GE Healthcare Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 China Isotope & Radiation
2.9.1 Business Overview
2.9.2 Radiopharmaceuticals Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Jubilant Pharma
2.10.1 Business Overview
2.10.2 Radiopharmaceuticals Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Eli Lilly
2.11.1 Business Overview
2.11.2 Radiopharmaceuticals Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eli Lilly Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Advanced Accelerator Applications
2.12.1 Business Overview
2.12.2 Radiopharmaceuticals Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 SIEMENS
2.13.1 Business Overview
2.13.2 Radiopharmaceuticals Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 SIEMENS Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Dongcheng
2.14.1 Business Overview
2.14.2 Radiopharmaceuticals Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Dongcheng Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Navidea
2.15.1 Business Overview
2.15.2 Radiopharmaceuticals Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Navidea Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Radiopharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Radiopharmaceuticals Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Radiopharmaceuticals Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Radiopharmaceuticals Manufacturer Market Share in 2018
3.3.2 Top 6 Radiopharmaceuticals Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Radiopharmaceuticals Market Analysis by Regions
4.1 Global Radiopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Radiopharmaceuticals Sales and Market Share by Regions (2014-2019)
4.1.2 Global Radiopharmaceuticals Revenue and Market Share by Regions (2014-2019)
4.2 North America Radiopharmaceuticals Sales and Growth Rate (2014-2019)
4.3 Europe Radiopharmaceuticals Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Radiopharmaceuticals Sales and Growth Rate (2014-2019)
4.5 South America Radiopharmaceuticals Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Radiopharmaceuticals Sales and Growth Rate (2014-2019)
5 North America Radiopharmaceuticals by Country
5.1 North America Radiopharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
5.1.2 North America Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
5.2 United States Radiopharmaceuticals Sales and Growth Rate (2014-2019)
5.3 Canada Radiopharmaceuticals Sales and Growth Rate (2014-2019)
5.4 Mexico Radiopharmaceuticals Sales and Growth Rate (2014-2019)
6 Europe Radiopharmaceuticals by Country
6.1 Europe Radiopharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
6.1.2 Europe Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
6.2 Germany Radiopharmaceuticals Sales and Growth Rate (2014-2019)
6.3 UK Radiopharmaceuticals Sales and Growth Rate (2014-2019)
6.4 France Radiopharmaceuticals Sales and Growth Rate (2014-2019)
6.5 Russia Radiopharmaceuticals Sales and Growth Rate (2014-2019)
6.6 Italy Radiopharmaceuticals Sales and Growth Rate (2014-2019)
7 Asia-Pacific Radiopharmaceuticals by Country
7.1 Asia-Pacific Radiopharmaceuticals Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
7.2 China Radiopharmaceuticals Sales and Growth Rate (2014-2019)
7.3 Japan Radiopharmaceuticals Sales and Growth Rate (2014-2019)
7.4 Korea Radiopharmaceuticals Sales and Growth Rate (2014-2019)
7.5 India Radiopharmaceuticals Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Radiopharmaceuticals Sales and Growth Rate (2014-2019)
8 South America Radiopharmaceuticals by Country
8.1 South America Radiopharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
8.1.2 South America Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
8.2 Brazil Radiopharmaceuticals Sales and Growth Rate (2014-2019)
8.3 Argentina Radiopharmaceuticals Sales and Growth Rate (2014-2019)
8.4 Colombia Radiopharmaceuticals Sales and Growth Rate (2014-2019)
9 Middle East and Africa Radiopharmaceuticals by Countries
9.1 Middle East and Africa Radiopharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Radiopharmaceuticals Sales and Growth Rate (2014-2019)
9.3 Turkey Radiopharmaceuticals Sales and Growth Rate (2014-2019)
9.4 Egypt Radiopharmaceuticals Sales and Growth Rate (2014-2019)
9.5 Nigeria Radiopharmaceuticals Sales and Growth Rate (2014-2019)
9.6 South Africa Radiopharmaceuticals Sales and Growth Rate (2014-2019)
10 Global Radiopharmaceuticals Market Segment by Type
10.1 Global Radiopharmaceuticals Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Radiopharmaceuticals Sales and Market Share by Type (2014-2019)
10.1.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
10.2 Diagnostic Radioisotopes Sales Growth and Price
10.2.1 Global Diagnostic Radioisotopes Sales Growth (2014-2019)
10.2.2 Global Diagnostic Radioisotopes Price (2014-2019)
10.3 Therapeutic Radioisotopes Sales Growth and Price
10.3.1 Global Therapeutic Radioisotopes Sales Growth (2014-2019)
10.3.2 Global Therapeutic Radioisotopes Price (2014-2019)
11 Global Radiopharmaceuticals Market Segment by Application
11.1 Global Radiopharmaceuticals Sales Market Share by Application (2014-2019)
11.2 Oncology Sales Growth (2014-2019)
11.3 Cardiology Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Radiopharmaceuticals Market Forecast (2019-2024)
12.1 Global Radiopharmaceuticals Sales, Revenue and Growth Rate (2019-2024)
12.2 Radiopharmaceuticals Market Forecast by Regions (2019-2024)
12.2.1 North America Radiopharmaceuticals Market Forecast (2019-2024)
12.2.2 Europe Radiopharmaceuticals Market Forecast (2019-2024)
12.2.3 Asia-Pacific Radiopharmaceuticals Market Forecast (2019-2024)
12.2.4 South America Radiopharmaceuticals Market Forecast (2019-2024)
12.2.5 Middle East and Africa Radiopharmaceuticals Market Forecast (2019-2024)
12.3 Radiopharmaceuticals Market Forecast by Type (2019-2024)
12.3.1 Global Radiopharmaceuticals Sales Forecast by Type (2019-2024)
12.3.2 Global Radiopharmaceuticals Market Share Forecast by Type (2019-2024)
12.4 Radiopharmaceuticals Market Forecast by Application (2019-2024)
12.4.1 Global Radiopharmaceuticals Sales Forecast by Application (2019-2024)
12.4.2 Global Radiopharmaceuticals Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Radiopharmaceuticals Picture
Table Product Specifications of Radiopharmaceuticals
Figure Global Sales Market Share of Radiopharmaceuticals by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
